Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

US FDA completes pre-approval inspection of Lupin’s edaravone oral suspension facility in Somerset with no observations: Our Bureau, Mumbai Monday, February 3, 2025, 14:45 Hrs [ ...

Lupin has announced that the the United States Food and Drug Administration (US FDA) has concluded the pre-approval inspection of the company's Edaravone Oral Suspension, located at its manufacturing ...

Lupin receives US FDA tentative approval for generic Symtuza tablets: Our Bureau, Mumbai Monday, February 3, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...

Earlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Stocks like GR Infraprojects,Anant Raj, Aarti Industries, Gujarat Gas, MOIL, Coal India, Indian Bank, Quess Corp, and HM Electro Mech will be in focus on February 3.

Pharma stocks had a mixed response after Finance Minister Nirmala Sitharaman announced customs duty exemptions for 36 ...

Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...

Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received ...

A new wave of hope is sweeping across Europe and MENA for millions of cancer patients seeking affordable and effective treatment options. The rise of generic oncology drugs is offering a much-needed ...